《IJID,5月31日,Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-06-01
  • Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity

    Author links open overlay panelChang KyungKanga1Gi-ChanHanbcd1MinjiKimbcd1GwanghunKimbcdHyun MuShinfKyoung-HoSongagPyoeng GyunChoeaWan BeomParkaEu SukKimafHong BinKimafNam-JoongKimaHang-RaeKimbcdefMyoung-donOha

    Show more

    https://doi.org/10.1016/j.ijid.2020.05.106

    Abstract

    Objectives

    We hypothesized that immune response may contribute to progression of coronavirus disease-19 (COVID-19) at the second week of illness. Therefore, we compared cell-mediated immune (CMI) responses between severe and mild COVID-19 cases.

    Methods

    We examined peripheral blood mononuclear cells of laboratory-confirmed COVID-19 patients from their first and third weeks of illness. Severe pneumonia was defined as an oxygen saturation ≤ 93% at room air. Expressions of molecules related to T-cell activation and functions were analyzed by flow cytometry.

  • 原文来源:https://www.sciencedirect.com/science/article/pii/S1201971220304136
相关报告
  • 《5月31日_细胞毒性T细胞的异常活化是COVID-19严重程度的潜在决定因素》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-06-01
    • 信息名称:细胞毒性T细胞的异常活化是COVID-19严重程度的潜在决定因素 1.时间:2020年5月31日 2.机构或团队:韩国首尔国立大学医学院 3.事件概要: 韩国首尔国立大学医学院在International Journal of Infectious Diseases发表论文“Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity”。 文章认为免疫应答可能在疾病的第二周导致COVID-19病情恶化,因此,文章比较了重症和轻症COVID-19病例的细胞介导免疫反应(cell-mediated immune,CMI),检测了实验室确诊的COVID-19患者发病第1周和第3周的外周血单个核细胞,利用流式细胞术分析与T细胞活化相关的分子表达。研究发现,两组T细胞在第一周时无明显差异。然而,在第三周,重症组的CD4+和CD8 + T细胞总数往往较低。重症组的CD4+或CD8+ T细胞中,Ki-67、PD-1、穿孔素和颗粒酶B在第三周的表达明显高于轻度组。经分析,文章认为重症COVID-19在发病后期,T细胞增殖、活化和细胞毒性程度较高,且未发生细胞毒性T细胞减少,这可能是导致重症的原因之一。 4.附件: 原文链接:https://www.sciencedirect.com/science/article/pii/S1201971220304136
  • 《IJID,5月31日,Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-06-01
    • Clinical Features and Short-term Outcomes of Elderly Patients With COVID-19 Author links open overlay panelPingLiaLuluChenaZhemingLiuaJinghuiPanaDingyiZhouaHuiWangaHongyunGongaZhenminFuaQibinSongaQianMinaShashaRuanaTangpengXuaFanChengbXiangpanLia Show more https://doi.org/10.1016/j.ijid.2020.05.107 Abstract Background The outbreak of Coronavirus Disease 2019 (COVID-19) has become a global public health emergency. Methods 204 elderly patients (≥60 years old) diagnosed with COVID-19 in Renmin Hospital of Wuhan University from January 31st to February 20th, 2020 were included in this study. Clinical endpoint was in-hospital death.